BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18347011)

  • 1. Suppression of hepatic glucose production by human neutrophil alpha-defensins through a signaling pathway distinct from insulin.
    Liu HY; Collins QF; Moukdar F; Zhuo D; Han J; Hong T; Collins S; Cao W
    J Biol Chem; 2008 May; 283(18):12056-63. PubMed ID: 18347011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.
    Liu HY; Wen GB; Han J; Hong T; Zhuo D; Liu Z; Cao W
    J Biol Chem; 2008 Nov; 283(45):30642-9. PubMed ID: 18786922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMT efficiently inhibits hepatic gluconeogenesis by regulating the Gαq signaling pathway.
    Zhou TT; Ma F; Shi XF; Xu X; Du T; Guo XD; Wang GH; Yu L; Rukachaisirikul V; Hu LH; Chen J; Shen X
    J Mol Endocrinol; 2017 Aug; 59(2):151-169. PubMed ID: 28637808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
    Sajan MP; Ivey RA; Lee MC; Farese RV
    J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
    Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
    J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
    De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
    J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
    Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
    Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
    Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
    J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geniposide and Gentiopicroside Suppress Hepatic Gluconeogenesis via Regulation of AKT-FOXO1 Pathway.
    Yang SQ; Chen YD; Li H; Hui X; Gao WY
    Arch Med Res; 2018 Jul; 49(5):314-322. PubMed ID: 30409503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice.
    González-Rodríguez A; Mas Gutierrez JA; Sanz-González S; Ros M; Burks DJ; Valverde AM
    Diabetes; 2010 Mar; 59(3):588-99. PubMed ID: 20028942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis.
    Fukushima A; Loh K; Galic S; Fam B; Shields B; Wiede F; Tremblay ML; Watt MJ; Andrikopoulos S; Tiganis T
    Diabetes; 2010 Aug; 59(8):1906-14. PubMed ID: 20484139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt/forkhead box class O1-dependent pathway in hepatocytes.
    Kitazawa M; Ohizumi Y; Oike Y; Hishinuma T; Hashimoto S
    J Pharmacol Exp Ther; 2007 Dec; 323(3):787-93. PubMed ID: 17804676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red Pepper (Capsicum annuum L.) Seed Extract Decreased Hepatic Gluconeogenesis and Increased Muscle Glucose Uptake In Vitro.
    Kim H; Cho KW; Jeong J; Park K; Ryu Y; Moyo KM; Kim HK; Go GW
    J Med Food; 2018 Jul; 21(7):665-671. PubMed ID: 29969359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans.
    Sajan MP; Ivey RA; Farese RV
    Metabolism; 2015 Nov; 64(11):1454-65. PubMed ID: 26386696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes.
    Chanda D; Kim DK; Li T; Kim YH; Koo SH; Lee CH; Chiang JY; Choi HS
    J Biol Chem; 2011 Aug; 286(32):27971-9. PubMed ID: 21693703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity.
    Sajan MP; Acevedo-Duncan ME; Standaert ML; Ivey RA; Lee M; Farese RV
    Diabetes; 2014 Aug; 63(8):2690-701. PubMed ID: 24705403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
    Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
    Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.